In a study conducted by Fatemah et al. the distinct expression profile of CYP1B1 in cervical cancer tissues compared to normal cervical tissues raises the possibility that CYP1B1 could be exploited as a therapeutic target in the future. This evidence concerns the gene CYP1B1 and cervical carcinoma.